Kidney Health
Renal health is integral to overall bodily functions, and the escalating prevalence of renal diseases poses significant challenges to public health. Hi-Q’s research delves into the comprehensive investigation of Oligo Fucoidan and FucoBalan® Fucoxanthin Fucoidan in promoting renal health. These components hold promise in positively impacting renal health by alleviating renal inflammation and damage, potentially slowing the progression of chronic kidney diseases. Moreover, the antifibrotic attributes of Oligo Fucoidan and Fucoxanthin might provide supportive measures against renal fibrosis.
Potential Benefits of Oligo Fucoidan and FucoBalan® Fucoxanthin Fucoidan in Kidney Health:
- Inhibit renal tubule interstitial fibrosis in chronic kidney disease (CKD)
- Exert protective effects on the kidneys of chronic kidney disease
- Ameliorate Acute Kidney Injury (AKI)
- Reduce AKI severity and promote kidney recovery of AKI (inhibiting kidney inflammation)
- Improves diabetes-induced renal fibrosis
Hi-Q’s Publications in Kidney Health Research
| 2022 | Oligosaccharides Ameliorate Acute Kidney Injury by Alleviating Cluster of Differentiation 44-Mediated Immune Responses in Renal Tubular Cells | |
|---|---|---|
| 2020 | Oligo-Fucoidan Improves Diabetes-Induced Renal Fibrosis via Activation of Sirt-1, GLP-1R, and Nrf2/HO-1: An In Vitro and In Vivo Study | |
| 2020 | Combined Protective Effects of Oligo-Fucoidan, Fucoxanthin, and L-Carnitine on the Kidneys of Chronic Kidney Disease Mice | |
| 2018 | Alleviative Effect of Fucoxanthin-Containing Extract from Brown Seaweed Laminaria Japonica on Renal Tubular Cell Apoptosis through Upregulating Na+/H+ Exchanger NHE1 in Chronic Kidney Disease Mice | |
| 2017 | Oligo-Fucoidan Prevents Renal Tubulointerstitial Fibrosis by Inhibiting the CD44 Signal Pathway |
*The Fucoidan and Fucoxanthin used in these studies were prepared by Hi-Q Marine Biotech